logo

Cortexyme Inc (CRTX)



Trade CRTX now with
  Date
  Headline
2/5/2014 7:31:00 AM Cornerstone Therapeutics Delisted From Nasdaq
2/4/2014 7:10:11 AM Chiesi Farmaceutici Completes Acquisition Of Cornerstone Therapeutics
2/3/2014 2:28:33 PM Cornerstone Therapeutics Stockholders Approve Merger With Chiesi Farmaceutici
11/7/2013 7:18:19 AM Cornerstone Therapeutics Q3 EPS $0.31 Vs $0.05 Prior Year
9/16/2013 7:32:34 AM Chiesi Farmaceutici To Acquire Cornerstone Therapeutics For $9.50 Per Share In Cash
8/6/2013 7:14:08 AM Cornerstone Therapeutics Q2 EPS $0.19 Vs. Loss $0.17 Last Year
7/29/2013 6:55:06 PM Cornerstone Therapeutics Initiates PERTZYE Sales And Marketing Efforts To Treat Exocrine Pancreatic Insufficiency
5/9/2013 7:08:52 AM Cornerstone Therapeutics Q1 Non-GAAP EPS More Than Quadruples To $0.24 From $0.05 Last Year
5/9/2013 6:50:06 AM Cornerstone Therapeutics Acquires Exclusive U.S. Marketing Rights To PERTZYE
3/14/2013 7:03:56 AM Cornerstone Therapeutics Q4 Loss/Shr $0.26 Vs. Loss $0.11 Last Year
2/20/2013 12:01:24 AM Cornerstone Therapeutics Announces Receipt Of Take-Private Proposal From Its Majority Stockholder Chiesi Farmaceutici
11/8/2012 7:36:30 AM Cornerstone Therapeutics Buys Exclusive U.S. Rights To Chiesi Farmaceutici S.p.A.'s BETHKIS
11/8/2012 7:17:18 AM Cornerstone Therapeutics Q3 EPS $0.05